| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.06 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.074 | 0.06 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.06 |